Co-Diagnostics, Inc. Announces Second Quarter 2024 Earnings Release Date and WebcastPRNewsWire • Thursday
Co-Diagnostics, Inc. Expands Vector Control Customer Base to 25 Customers across 15 U.S. StatesPRNewsWire • 07/02/24
Co-Diagnostics, Inc. Submits First FDA 510(k) Application for Co-Dx PCR Pro PlatformPRNewsWire • 06/14/24
Co-Diagnostics, Inc. Announces First Quarter 2024 Earnings Release Date and WebcastPRNewsWire • 04/25/24
Co-Diagnostics, Inc. to Host Booth and Deliver Presentation at APRC 2024 in TaiwanPRNewsWire • 04/24/24
Co-Diagnostics, Inc. Inaugurates New Manufacturing Facility in Utah with Ribbon Cutting EventPRNewsWire • 04/12/24
Co-Diagnostics, Inc. CEO Delivers Manufacturing and Commercialization Update in Conference Keynote AddressPRNewsWire • 03/21/24
Co-Diagnostics, Inc. CEO to Deliver Keynote Address at MarketsandMarkets 2024 in London, EnglandPRNewsWire • 03/18/24
Co-Diagnostics, Inc. JV CoSara Receives Clearance from Indian Regulators for Influenza Multiplex PCR TestPRNewsWire • 03/07/24
Co-Diagnostics, Inc. Announces Fourth Quarter and Full Year 2023 Earnings Release Date and WebcastPRNewsWire • 02/29/24
Co-Diagnostics, Inc. Shares List of Upcoming Industry Conferences and Events for February 2024PRNewsWire • 02/01/24
Co-Diagnostics, Inc. to Participate in the Piper Sandler 35th Annual Healthcare Conference in New York City on November 30, 2023PRNewsWire • 11/29/23
Co-Diagnostics, Inc. Announces Additional Grant Award for Tuberculosis Test in DevelopmentPRNewsWire • 11/02/23
Co-Diagnostics, Inc. Shares List of Upcoming Industry Conferences and Events for November 2023PRNewsWire • 10/31/23
Co-Diagnostics, Inc. Announces Third Quarter 2023 Earnings Release Date and WebcastPRNewsWire • 10/26/23